Fluorescent dendrimers with a peptide cathepsin B cleavage site for drug delivery applications

Chemical Communications

Volumn , Issue 14, 2005, Pages 1830-1832

  Fuchs, Sabine ^a   Otto, Henning ^a   Jehle, Stefan ^a,b   Henklein, Peter ^b   Schlüter, A Dieter ^a,c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; DENDRIMER; DNA; LIGAND; OLIGOPEPTIDE; PENTAPEPTIDE; PLATINUM; PROTEINASE;

ARTICLE; CELLULAR DISTRIBUTION; CHELATION; CHEMICAL STRUCTURE; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HELA CELL; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDE SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID PHASE SYNTHESIS; SYNTHESIS;

EID: 17444367675     PISSN: 13597345     EISSN: None     Source Type: Journal    
DOI: 10.1039/b415651j     Document Type: Article

References (38)

1. (a) S.-E. Stibira, H. Frey and R. Haag, Angew. Chem., Int. Ed., 2002, 41, 1329-1334;
2. (b) R. Esfand and D. A. Tomalia, Drug Discovery Today, 2001, 6, 427-436;
3. (c) M. Liu, K. Kono and J. M. J. Fréchet, Polym. Mater. Sci. Eng., 1998, 79, 269-270.
4. (a) J. R. Baker, Jr., A. U. Bielinska and J. F. Kukowska-Latallo, Methods Mol. Biol., 2004, 245, 67-81;
5. (b) J. Dennig, Top. Curr. Chem., 2003, 228, 227-236;
6. (c) J. Dennig and E. Duncan. Rev. Mol. Biotechnol., 2002, 90, 339-347.
7. (a) H. Kobayashi and M. W. Brechbiel, Mol. Imaging, 2003, 2, 1-10;
8. (b) W. Krause, N. Hackmann-Schlichter, F. K. Maier and R. Muller, Top. Curr. Chem., 2000, 210, 261-308;
9. (c) Y. Kim and S. C. Zimmerman, Curr. Opin. Chem. Biol., 1998, 2, 733-742.
10. (a) L. H. Bryant, Jr. and J. W. M. Bulte, Focus Biotechnol., 2001, 7, 47-69;
11. (b) B. Qualmann, M. M. Kessels, H.-J. Musiol, W. D. Sierralta, P. W. Jungblut and L. Moroder, Angew. Chem., Int. Ed., 1996, 35, 909-911.
12. (a) D. Shabat, R. J. Roey, A. Gopin, N. Pessah and M. Shamis, Chem. Eur. J., 2004, 10, 2626-2634;
13. (b) U. Boas and P. M. H. Heegaard, Chem. Soc. Rev., 2004, 33, 43-63;
14. (c) F. Aulenta, W. Hayes and S. Rannard, Eur. Polym. J., 2003, 39, 1741-1771;
15. (d) M. J. Cloninger, Curr. Opin. Chem. Biol., 2002, 6, 742-748.
16. For example see: (a) C. Kojima, Y. Haba, T. Fukui, K. Kono and T. Takagishi, Macromolecules, 2003, 36, 2183-2186;
17. (b) S. Stevelmans, J. C. M. van Hest, J. F. G. A. Jansen, D. A. F. J. van Boxtel, E. M. M. de Brabander-van den Berg and E. W. Meijer, J. Am. Chem. Soc., 1996, 118, 7398-7399.
18. For example see: O. L. Padilla De Jesus, H. R. Ihre, L. Gagne, J. M. J. Fréchet and F. C. Szoka, Jr., Bioconjugate Chem., 2002, 13, 453-461.
19. (a) K. Ulbrich, T. Etrych, P. Chytil, M. Jelinkova and B. Rihova, J. Controlled Release, 2003, 87, 33-47;
20. (b) E. Gianasi, M. Wasil, E. G. Evagorou, A. Keddle, G. Wilson and R. Duncan, Eur. J. Cancer, 1999, 35, 994-1002.
21. D. Musil, D. Zucic, D. Turk, R. A. Engh, I. Mayr, R. Huber, T. Popovic, V. Turk, T. Towatari, N. Katunuma and W. Bode, EMBO J., 1991, 10, 2321-2330.
22. (a) V. Turk, B. Turk and D. Turk, EMBO J., 2001, 20, 4629-4633:
23. (b) F. Lecaille, J. Kaleta and D. Brömme, Chem. Rev., 2002, 102, 4459-4488.
24. B. F. Sloane, K. V. Honor, J. G. Sadler, W. A. Turner, J. J. Kimpson and J. D. Taylor, Cancer Res., 1982, 42, 980-986.
25. S. Fuchs. T. Kapp, H. Otto, T. Schöneberg, P. Franke, R. Gust and A. D. Schlüter, Chem. Eur. J., 2004, 5, 1167-1192.
26. C. Sergheraert, P. Mäes and A. Tartar, J. Chem. Soc., Perkin Trans, 1, 1986, 1061-1064.
27. N. Malik, E. G. Evagorou and R. Duncan, Anti-Cancer Drugs, 1999, 10, 767-776.
28. (a) P. J. Julyan, L. W. Seymour, D. R. Ferry, S. Daryani, C. M. Boivin, J. Doran, M. David, D. Anderson, C. Christodoulou, A. M. Young, S. Hesslewood and D. J. Kerr, J. Controlled Release, 1999, 57, 281-290;
29. (b) O. L. Padilla De Jesus, H. R. Ihre, L. Gagne, J. M. J. Fréchet and F. C. Szoka, Jr., Bioconjugate Chem., 2002, 13, 453-461.
30. K. Barlos, O. Chatzi, D. Gatos and G. Stavropoulos, Int. J. Pept. Protein Res., 1991, 37, 513-520.
31. Column chromatography over silica gel (dichloromethane cont. 5% methanol as eluent).
32. K. Kitagawa, C. Aida, H. Fujiwara, T. Yagami, S. Futaki, M. Kogire, J. Ida and K. Inoue, J. Org. Chem., 2001, 66, 1-10.
33. A. Carpino, H. Shroff, S. A. Triolo, E.-S. M. E. Mansour, H. Wenschuh and F. Albericio, Tetrahedron Lett., 1993, 34, 7829-7832.
34. For example see: (a) A. Quintana, E. Raczka, L. Piehler, I. Lee, A. Myc, I. Majoros, A. K. Patri, T. Thomas, J. Mulé and J. R. Baker, Jr., Pharm. Res., 2002, 19, 1310-1316;
35. (b) O. L. Padilla De Jesus, H. R. Ihre, L. Gagne, J. M. J. Fréchet and F. C. Szoka, Jr., Bioconjugate Chem., 2002, 13, 453-461;
36. (c) L. Crespo, G. Sanclimens, B. Montaner, R. Pérez-Tomás, M. Royo, M. Pons, F. Albericio and E. Giralt, J. Am. Chem. Soc., 2002, 124, 8876-8883.
37. (a) H. Yoo and R. L. Juliano, Nucleic Acids Res., 2000, 28, 4225-4231;
38. (b) R. DeLong, K. Stephenson, T. Loftus, M. Fisher, S. Alahari, A. Nolting and R. L. Juliano, J. Pharm. Sci., 1997, 86, 762-764.